HWAY:NGS-Healthways Inc. (USD)

EQUITY | Others | Nasdaq Global Select

Last Closing

USD 23.78

Change

-1.43 (-5.68)%

Market Cap

USD 0.89B

Volume

1.56K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Healthways Inc provides comprehensive total population health management solutions that are designed to help people improve their well-being, thereby improving their health and productivity and reducing their health-related costs.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-03 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
IBIT iShares Bitcoin Trust

+3.24 (+7.43%)

USD 50.95B
QQQM Invesco NASDAQ 100 ETF

+20.12 (+11.74%)

USD 39.48B
JEPQ JPMorgan Nasdaq Equity Premium..

+4.81 (+10.48%)

USD 22.06B
ACWI iShares MSCI ACWI ETF

+9.11 (+8.79%)

USD 18.95B
CGABL The Carlyle Group Inc. 4.625% ..

+0.29 (+1.70%)

USD 16.14B
SNDK Sandisk Corp

+4.23 (+13.08%)

USD 5.99B
TBIL Rbb Fund Inc - Us Treasury 3 M..

+0.02 (+0.04%)

USD 5.17B
TSLL Direxion Shares ETF Trust - Di..

+3.07 (+45.21%)

USD 3.11B
NVDL GraniteShares 1.5x Long NVDA D..

+10.40 (+35.86%)

USD 3.04B
ETHA iShares Ethereum Trust ETF

+1.35 (+12.20%)

USD 2.37B

ETFs Containing HWAY

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -9.44% 32% F 54% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -9.44% 32% F 53% F
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization 0.89B 3% F 1% F

Key Financial Ratios

  Ratio vs. Industry/Classification (Others) Ratio vs. Market (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio N/A N/A N/A
Price/Book Ratio N/A N/A N/A
Price / Cash Flow Ratio N/A N/A N/A
Price/Free Cash Flow Ratio N/A N/A N/A
Management Effectiveness  
Return on Equity N/A N/A N/A
Return on Invested Capital N/A N/A N/A
Return on Assets N/A N/A N/A
Debt to Equity Ratio N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.